Abstract

BackgroundElectroacupuncture (EA) is reported to be an effective treatment for obesity, but its mechanism is unclear. This study aimed to investigate the relationship between hypothalamic LKB1-AMPK-ACC signaling and EA.MethodsFifty male Sprague–Dawley rats were divided into two groups fed either chow (chow-fed group) or high-fat diet (HF group). After 4 weeks of feeding, obese rats in the HF group (defined as weighing 20 % or more than rats in the chow-fed group) were randomly allocated into an EA or Diet-induced obesity (DIO) group. The EA group was given EA on bilateral ST25–ST36 for 4 weeks, while the DIO group received no further intervention. Body weight of the chow-fed, DIO, and EA groups were measured weekly. mRNA and protein levels of the hypothalamic LKB1-AMPK-ACC signaling pathway were detected using real-time (RT)-PCR and western blot, respectively.ResultsAfter 4 weeks of EA treatment, the weight growth trend of rats in the EA group was inhibited compared with those in the DIO group. RT-PCR and western blotting showed that EA upregulated the transcription of Adenosine 5′-monophosphate -activated protein kinase α2 (AMPKα2), promoted protein expression of Liver kinase B1 (LKB1) and AMPKα1, and inhibited acetyl-CoA carboxylase (ACC) protein expression in the hypothalamus.ConclusionsThis study suggests that hypothalamic LKB1-AMPK-ACC signaling plays an important role in EA treatment for obesity.

Highlights

  • Electroacupuncture (EA) is reported to be an effective treatment for obesity, but its mechanism is unclear

  • We investigated the role of hypothalamic Liver kinase B1 (LKB1)-Adenosine 5′-monophosphate -activated protein kinase (AMPK)-acetyl-CoA carboxylase (ACC) signaling in the obesity pathology and EA treatment mechanism

  • Our results demonstrate that EA rats had significantly higher protein levels of LKB1 and pAMPKα1 compared with diet-induced obesity (DIO) rats

Read more

Summary

Introduction

Electroacupuncture (EA) is reported to be an effective treatment for obesity, but its mechanism is unclear. Several investigations into curbing the increasing obese population have been conducted, but there are few effective pharmacological treatments. Three drugs have been approved by the US Food and Drug Administration for long-term obesity treatment, namely lorcaserin (Belviq), phentermine plus topiramate (Qsymia), and orlistat (Xenical, Alli) [2]. Acupuncture is one of the most popular alternative therapies, and it has been used to treat obesity for thousands of years. Recent systematic reviews indicate that EA is an effective treatment for obesity [4]. The mechanism of EA on obesity needs further investigation. The possible mechanisms underlying the effect of EA focus on the hypothalamus [5, 6]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call